Alberto F García1,2,3, Ramiro Manzano-Nunez4,5, Claudia P Orlas6, Juan Ruiz-Yucuma3, Alejandra Londoño3, Camilo Salazar3, Juan Melendez2, Álvaro I Sánchez1, Juan Carlos Puyana7, Carlos A Ordoñez1,2,3. 1. Fundacion Valle del Lili University Hospital, Clinical Research Center, Cali, Colombia. 2. Department of Surgery, Universidad del Valle, Cali, Colombia. 3. School of Medicine, Universidad ICESI, Cali, Colombia. 4. Fundacion Valle del Lili University Hospital, Clinical Research Center, Cali, Colombia. Ramiro.manzano@fvl.org.co. 5. Clinical Research Center, Fundacion Valle del Lili, Cali, Colombia. Ramiro.manzano@fvl.org.co. 6. Brigham and Women's Hospital, Department of Surgery, Center for Surgery and Public Health, Boston, MA, USA. 7. Department of Surgery, University of Pittsburg, Pittsburgh, PA, USA.
Abstract
PURPOSE: The purpose of this study was to examine the association of REBOA and mortality in a group of patients with penetrating trauma to the torso, treated in a level-I trauma center from Colombia. METHODS: In a retrospective cohort study, patients with penetrating trauma, requiring emergency surgery, and treated between 2014 and 2018, were included. The decision to use or not use REBOA during emergent surgery was based on individual surgeon's opinion. A propensity score (PS) was calculated after adjusting for age, clinical signs on admission (systolic blood pressure, cardiac rate, Glasgow coma scale), severe trauma in thorax and abdomen, and the presence of non-compressive torso hemorrhage. Subsequently, logistic regression for mortality was adjusted for the number of red blood cells (RBC) transfused within the first six hours after admission, injury severity score (ISS), and quintiles of PS. RESULTS: We included 345 patients; 28 of them (8.1%) were treated with REBOA. Crude mortality rates were 17.9% (5 patients) in REBOA group and 15.3% (48 patients) in control group (p = 0.7). After controlling for RBC transfused, ISS, and the PS, the odds of death in REBOA group was 78% lower than that in the control group (odds ratio [OR] 0.20, 95% confidence interval [95%CI] 0.05-0.77, p = 0.01). CONCLUSION: We found that, when compared to no REBOA use, patients treated with REBOA had lower risk-adjusted odds of mortality. These findings should be interpreted with caution and confirmed in future comparative studies, if possible.
PURPOSE: The purpose of this study was to examine the association of REBOA and mortality in a group of patients with penetrating trauma to the torso, treated in a level-I trauma center from Colombia. METHODS: In a retrospective cohort study, patients with penetrating trauma, requiring emergency surgery, and treated between 2014 and 2018, were included. The decision to use or not use REBOA during emergent surgery was based on individual surgeon's opinion. A propensity score (PS) was calculated after adjusting for age, clinical signs on admission (systolic blood pressure, cardiac rate, Glasgow coma scale), severe trauma in thorax and abdomen, and the presence of non-compressive torso hemorrhage. Subsequently, logistic regression for mortality was adjusted for the number of red blood cells (RBC) transfused within the first six hours after admission, injury severity score (ISS), and quintiles of PS. RESULTS: We included 345 patients; 28 of them (8.1%) were treated with REBOA. Crude mortality rates were 17.9% (5 patients) in REBOA group and 15.3% (48 patients) in control group (p = 0.7). After controlling for RBC transfused, ISS, and the PS, the odds of death in REBOA group was 78% lower than that in the control group (odds ratio [OR] 0.20, 95% confidence interval [95%CI] 0.05-0.77, p = 0.01). CONCLUSION: We found that, when compared to no REBOA use, patients treated with REBOA had lower risk-adjusted odds of mortality. These findings should be interpreted with caution and confirmed in future comparative studies, if possible.
Authors: David Thomas McGreevy; Fikri M Abu-Zidan; Mitra Sadeghi; Artai Pirouzram; Asko Toivola; Per Skoog; Koji Idoguchi; Yuri Kon; Tokiya Ishida; Yosuke Matsumura; Junichi Matsumoto; Viktor Reva; Mariusz Maszkowski; Adam Bersztel; Eva-Corina Caragounis; Mårten Falkenberg; Lauri Handolin; George Oosthuizen; Endre Szarka; Vassil Manchev; Tongporn Wannatoop; Sung Wook Chang; Boris Kessel; Dan Hebron; Gad Shaked; Miklosh Bala; Federico Coccolini; Luca Ansaloni; Carlos A Ordoñez; Emanuel M Dogan; James E Manning; Peter Hibert-Carius; Thomas Larzon; Kristofer F Nilsson; Tal Martin Hörer Journal: Shock Date: 2020-08 Impact factor: 3.454
Authors: Carlos A Ordoñez; Michael W Parra; Yaset Caicedo; Natalia Padilla; Fernando Rodríguez-Holguín; José Julián Serna; Alexander Salcedo; Alberto García; Claudia Orlas; Luis Fernando Pino; Ana Milena Del Valle; David Mejia; Juan Carlos Salamea-Molina; Megan Brenner; Tal Hörer Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Carlos A Ordoñez; Michael W Parra; José Julián Serna; Fernando Rodríguez-Holguin; Alberto García; Alexander Salcedo; Yaset Caicedo; Natalia Padilla; Luis Fernando Pino; Adolfo González Hadad; Mario Alain Herrera; Mauricio Millán; Laureano Quintero-Barrera; Fabian Hernández-Medina; Ricardo Ferrada; Megan Brenner; Todd Rasmussen; Thomas Scalea; Rao Ivatury; John B Holcomb Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Marianne A Thrailkill; Kevin H Gladin; Catherine R Thorpe; Teryn R Roberts; Jae H Choi; Kevin K Chung; Corina N Necsoiu; Todd E Rasmussen; Leopoldo C Cancio; Andriy I Batchinsky Journal: Scand J Trauma Resusc Emerg Med Date: 2021-01-06 Impact factor: 2.953
Authors: Alberto García; Mauricio Millán; Daniela Burbano; Carlos A Ordoñez; Michael W Parra; Adolfo González Hadad; Mario Alain Herrera; Luis Fernando Pino; Fernando Rodríguez-Holguín; Alexander Salcedo; María Josefa Franco; Ricardo Ferrada; Juan Carlos Puyana Journal: Colomb Med (Cali) Date: 2021-06-30
Authors: Megan Brenner; Bishoy Zakhary; Raul Coimbra; Jonathan Morrison; Thomas Scalea; Laura J Moore; Jeanette Podbielski; John B Holcomb; Kenji Inaba; Jeremy W Cannon; Mark Seamon; Chance Spalding; Charles Fox; Ernest E Moore; Joseph Abdellatif Ibrahim Journal: Trauma Surg Acute Care Open Date: 2022-03-16
Authors: Yaset Caicedo; Linda M Gallego; Hugo Jc Clavijo; Natalia Padilla-Londoño; Cindy-Natalia Gallego; Isabella Caicedo-Holguín; Mónica Guzmán-Rodríguez; Juan J Meléndez-Lugo; Alberto F García; Alexander E Salcedo; Michael W Parra; Fernando Rodríguez-Holguín; Carlos A Ordoñez Journal: Eur J Med Res Date: 2022-10-17 Impact factor: 4.981
Authors: Alberto García; Mauricio Millán; Carlos A Ordoñez; Daniela Burbano; Michael W Parra; Yaset Caicedo; Adolfo González Hadad; Mario Alain Herrera; Luis Fernando Pino; Fernando Rodríguez-Holguín; Alexander Salcedo; Maria Josefa Franco; Ricardo Ferrada; Juan Carlos Puyana Journal: Colomb Med (Cali) Date: 2021-05-10
Authors: Ramiro Manzano-Nunez; David McGreevy; Claudia P Orlas; Alberto F García; Tal M Hörer; Joseph DuBose; Carlos A Ordoñez Journal: World J Emerg Surg Date: 2020-10-12 Impact factor: 5.469